The relationship between human muth homolog 1 gene mutation at site 415 and sporadic colon cancers in Chinese Han population

1. Harnack L, Jacobs DR, Nicodemus K, Lazovich D, Anderson K, Folsom AR. Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer. 2002; 43:152-8.10.1207/S15327914NC432_512588695Search in Google Scholar

2. Renkonen E, Lohi H, Jarvinen HJ, Mecklin JP, Peltomaki P. Novel splicing associations of hereditary colon cancer related DNA mismatch repair gene mutations. J Med Genet. 2004; 41:e95.10.1136/jmg.2003.017269173583215235038Open DOISearch in Google Scholar

3. Sergent C, Franco N, Chapusot C, Lizard-Nacol S, Isambert N, Correia M, et al. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins. Cancer Chemother Pharmacol. 2002, 49: 445-52.10.1007/s00280-002-0450-612107548Search in Google Scholar

4. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004; 10:789-99.10.1038/nm108715286780Search in Google Scholar

5. Vogelsang M, Comino A, Zupanec N, Hudler P, Komel R. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast. BMC Cancer. 2009; 9:382.10.1186/1471-2407-9-382277379119863800Open DOISearch in Google Scholar

6. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci USA. 2003; 100:776-81.10.1073/pnas.033485810029867712552134Open DOISearch in Google Scholar

7. Boland CR, Goel A. The silence of the genes: matching mismatch repair defects with tumors. Cancer. 2003; 98: 2091-4.10.1002/cncr.1176914601077Open DOISearch in Google Scholar

8. Gallinger S, Aronson M, Shayan K, Ratcliffe EM, Gerstle JT, Parkin PC, et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology. 2004; 126:576-85.10.1053/j.gastro.2003.11.00814762794Search in Google Scholar

9. Liu J, Albarracin CT, Chang KH, Thompson-Lanza JA, Zheng W, Gershenson DM, et al. Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer. Mod Pathol. 2004; 17:75-80.10.1038/modpathol.380001714631366Search in Google Scholar

10. Zhang XM, Li JT, Zhu M, Wu XL, Gao P, Zhou P, et al. Study on the relationship between genetic polymorphism Va1384Asp in hMLH1 gene and risk of four different carcinomas. Chin J Epidemiology. 2004, 25:978-81.Search in Google Scholar

11. Lipkin SM, Rozek LS, Rennert G, Yang W, Chen PC, Hacia J, et al. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nat Genet. 2004, 36:694-9.10.1038/ng137415184898Search in Google Scholar

12. Shin BY, Chen H, Rozek LS, Paxton L, Peel DJ, Anton- Culver H, et al. Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patients. Dis Colon Rectum. 2005; 48:1723-7.10.1007/s10350-005-0123-8Search in Google Scholar

13. Schafmayer C, Buch S, Egberts JH, Franke A, Brosch M, EI Sharawy A, et al. Genetic investigation of DNArepair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer. 2007; 121:555-8.10.1002/ijc.22735Search in Google Scholar

14. Chaves P, Cruz C, Larg P, Cravo M, Leitao CN, Soares J. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol. 2000; 191:355-60.10.1002/1096-9896(2000)9999:9999<::AID-PATH644>3.0.CO;2-TSearch in Google Scholar

15. Kim JC, Roh SA, Koo KH, Ka IH, Kim HC, Yu CS, et al. Genotyping possible polymorphic variants of human mismatch repair gene in healthy Korean individuals and sporadic colorectal cancer patients. Fam Cancer. 2004; 3:129-37.10.1023/B:FAME.0000039919.66461.8fSearch in Google Scholar

16. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993; 260:812-6.10.1126/science.8484121Search in Google Scholar

17. Hendriks YM, de Jong AE, Morreau H, Tops CM, Vasen HF, Wijnen JT, et al. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin. 2006; 56:213-25.10.3322/canjclin.56.4.213Search in Google Scholar

18. Mori S, Ogata Y, Shirouzu K. Biological features of sporadic colorectal carcinoma with high-freguency micrisatellite instability: special reference to tumor proliferation and apoptosis. Int J Clin Oncol. 2004; 9: 322-9.10.1007/s10147-004-0406-4Open DOISearch in Google Scholar

19. Chapusot C, Martin L, Mungra N, Rageot D, Bouvier AM, Bonithon Kopp C, et al. Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: proteins and clinicopathological features of 273 adenocarcinomas. Histopathology. 2003; 43:40-47.10.1046/j.1365-2559.2003.01641.xSearch in Google Scholar

20. Rahner N, Friedrichs N, Steinke V, Aretz S, Friedl W, Buettner R, et al. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome. J Pathol. 2008; 214: 10-16.10.1002/path.2263Search in Google Scholar